Market Cap 547.64B
Revenue (ttm) 94.19B
Net Income (ttm) 26.80B
EPS (ttm) N/A
PE Ratio 21.50
Forward PE 19.93
Profit Margin 28.46%
Debt to Equity Ratio 0.48
Volume 7,174,563
Avg Vol 8,279,580
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 20%
Beta 0.34
Analysts Strong Sell
Price Target $259.50

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospit...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
backtesttrend
backtesttrend Apr. 28 at 8:31 PM
Are the targets factoring in cyclical mean reversion? 📊 Margin expansion in memory is real, but parabolic moves invite gamma unwinds. Trim into strength, hedge tail risk with puts. Capital preservation > chasing prints. $MU $CAT $JNJ 👉If this helps, tap @backtesttrend
0 · Reply
DragonAlgo
DragonAlgo Apr. 28 at 5:01 PM
🐉 $JNJ CALL — DragonAlgo® Signal Contract: JNJ CALL Expiry: 2026-05-01 | Strike: $227.50 | Type: CALL Option Plan (premium): Entry: $3.13 Stop: $2.26 TP1: $4.08 TP2: $5.33 TP3: $7.52 Risk preset by model constraints. 🔗 https://dragonalgo.com
0 · Reply
MeanReverter_
MeanReverter_ Apr. 28 at 4:25 PM
Headline just hit and this is the kind of macro catalyst traders can’t ignore Trump is bringing major players to the White House — spanning semis, autos, steel, pharma, and AI infra. That’s not random… that’s capital allocation + policy direction in real time. Here’s how I’m reading the flow: • $NVDA → still the king of AI infra. Any renewed push = tailwind • $TSM → direct beneficiary of U.S. chip reshoring narrative • $TM → foreign auto giant, could gain from localized production incentives • $JNJ → tied to domestic pharma expansion, policy support matters • $CLF → classic sleeper, steel demand rises if U.S. manufacturing ramps This isn’t just headlines — this is positioning for where money could rotate next. Watch volume + relative strength closely. If this gains traction, these names won’t stay quiet for long. Stay sharp — narratives like this can reprice sectors fast. Curious about the full approach?👉 Check the @MeanReverter_
0 · Reply
NRG8
NRG8 Apr. 28 at 3:09 PM
0 · Reply
DeadInvestor
DeadInvestor Apr. 28 at 2:41 PM
$TVTX This should be around $65 / share, or roughly mrkt cap 2x peak sales of $3.1 billion. Awaiting news to leak on potential acquirers, such as $LLY or $NVS or $JNJ or $AZN . $75 to $80 take out price well within the realm of possibility. But, if share price doesn’t climb from this $40 floor, buyout price might be undervalued.
0 · Reply
NewEarth
NewEarth Apr. 28 at 12:01 PM
0 · Reply
Goldenpoint9
Goldenpoint9 Apr. 28 at 9:24 AM
0 · Reply
grampslol
grampslol Apr. 28 at 9:01 AM
Poor $MNKD pumper clan...smh... deluding himself as he tries to deceive others about this pennyland inhaled insulin flop drug company...he knows it's Afizzle $IBB $SPY $JNJ
0 · Reply
clan
clan Apr. 28 at 8:28 AM
$MNKD Follow the pros.🤑 Ignore the triggered trolls👹. Inhale your insulin.🚫💉 MNKD up and to the right from here.↗️ Multiple approvals incoming. Load the boat. BULLISH🐂 Mannkind Corp. = premier bio. co. $SPY $IBB $JNJ
0 · Reply
focafoca99
focafoca99 Apr. 28 at 5:42 AM
$JNJ entered the calendar for Bernstein's Strategic Decisions Conference with a planned company appearance. https://www.rapidticker.com/news/jnj-johnson-amp-johnson-to-participate-b6d983
0 · Reply
Latest News on JNJ
Why These 3 Forever Stocks Belong on Your Watchlist

Apr 28, 2026, 11:10 AM EDT - 7 hours ago

Why These 3 Forever Stocks Belong on Your Watchlist

WMT XOM


Johnson & Johnson Transcript: AGM 2026

Apr 23, 2026, 10:00 AM EDT - 5 days ago

Johnson & Johnson Transcript: AGM 2026


Johnson & Johnson CFO on the company's robotic surgical system

Apr 14, 2026, 10:51 AM EDT - 14 days ago

Johnson & Johnson CFO on the company's robotic surgical system


Johnson & Johnson Earnings Call Transcript: Q1 2026

Apr 14, 2026, 8:30 AM EDT - 14 days ago

Johnson & Johnson Earnings Call Transcript: Q1 2026


J&J raises guidance for 2026 on strong start to the year

Apr 14, 2026, 6:55 AM EDT - 14 days ago

J&J raises guidance for 2026 on strong start to the year


Johnson & Johnson reports Q1 2026 results, raises 2026 outlook

Apr 14, 2026, 6:20 AM EDT - 14 days ago

Johnson & Johnson reports Q1 2026 results, raises 2026 outlook


J&J's First-Quarter Sales Grow on Cancer-Drug Strength

Apr 14, 2026, 6:20 AM EDT - 14 days ago

J&J's First-Quarter Sales Grow on Cancer-Drug Strength


The Big 3: ORCL, JNJ, SBUX

Mar 19, 2026, 1:00 PM EDT - 5 weeks ago

The Big 3: ORCL, JNJ, SBUX

ORCL SBUX


US FDA approves J&J's oral psoriasis pill

Mar 18, 2026, 8:31 AM EDT - 5 weeks ago

US FDA approves J&J's oral psoriasis pill


US FDA approves JNJ's blood cancer drug

Mar 5, 2026, 2:21 PM EST - 7 weeks ago

US FDA approves JNJ's blood cancer drug


Does JNJ Stock Still Offer Value?

Feb 23, 2026, 11:35 AM EST - 2 months ago

Does JNJ Stock Still Offer Value?


Johnson & Johnson Earnings Call Transcript: Q4 2025

Jan 21, 2026, 8:30 AM EST - 3 months ago

Johnson & Johnson Earnings Call Transcript: Q4 2025


Johnson & Johnson Earnings Call Transcript: Q3 2025

Oct 14, 2025, 8:30 AM EDT - 7 months ago

Johnson & Johnson Earnings Call Transcript: Q3 2025


Johnson & Johnson Earnings Call Transcript: Q2 2025

Jul 16, 2025, 8:30 AM EDT - 10 months ago

Johnson & Johnson Earnings Call Transcript: Q2 2025


Johnson & Johnson Transcript: AGM 2025

Apr 24, 2025, 10:00 AM EDT - 1 year ago

Johnson & Johnson Transcript: AGM 2025


Johnson & Johnson Earnings Call Transcript: Q1 2025

Apr 15, 2025, 8:30 AM EDT - 1 year ago

Johnson & Johnson Earnings Call Transcript: Q1 2025


Johnson & Johnson Transcript: Investor Update

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Johnson & Johnson Transcript: Investor Update


Johnson & Johnson Earnings Call Transcript: Q4 2024

Jan 22, 2025, 8:00 AM EST - 1 year ago

Johnson & Johnson Earnings Call Transcript: Q4 2024


Johnson & Johnson Transcript: Stifel 2024 Healthcare Conference

Nov 18, 2024, 10:55 AM EST - 1 year ago

Johnson & Johnson Transcript: Stifel 2024 Healthcare Conference


Johnson & Johnson Earnings Call Transcript: Q3 2024

Oct 15, 2024, 8:30 AM EDT - 1 year ago

Johnson & Johnson Earnings Call Transcript: Q3 2024


Johnson & Johnson Earnings Call Transcript: Q2 2024

Jul 17, 2024, 8:30 AM EDT - 1 year ago

Johnson & Johnson Earnings Call Transcript: Q2 2024


Johnson & Johnson Transcript: BofA Healthcare Conference

May 14, 2024, 4:40 PM EDT - 2 years ago

Johnson & Johnson Transcript: BofA Healthcare Conference


Johnson & Johnson Transcript: AGM 2024

Apr 25, 2024, 10:00 AM EDT - 2 years ago

Johnson & Johnson Transcript: AGM 2024


Johnson & Johnson Earnings Call Transcript: Q1 2024

Apr 16, 2024, 8:30 AM EDT - 2 years ago

Johnson & Johnson Earnings Call Transcript: Q1 2024


Johnson & Johnson Transcript: M&A Announcement

Apr 5, 2024, 8:30 AM EDT - 2 years ago

Johnson & Johnson Transcript: M&A Announcement


Johnson & Johnson Earnings Call Transcript: Q4 2023

Jan 23, 2024, 8:30 AM EST - 2 years ago

Johnson & Johnson Earnings Call Transcript: Q4 2023


Johnson & Johnson Transcript: Investor Update

Dec 5, 2023, 10:00 AM EST - 2 years ago

Johnson & Johnson Transcript: Investor Update


Johnson & Johnson Earnings Call Transcript: Q3 2023

Oct 17, 2023, 8:30 AM EDT - 2 years ago

Johnson & Johnson Earnings Call Transcript: Q3 2023


Johnson & Johnson Earnings Call Transcript: Q2 2023

Jul 20, 2023, 8:30 AM EDT - 3 years ago

Johnson & Johnson Earnings Call Transcript: Q2 2023


Johnson & Johnson Earnings Call Transcript: Q1 2023

Apr 18, 2023, 8:30 AM EDT - 3 years ago

Johnson & Johnson Earnings Call Transcript: Q1 2023


Johnson & Johnson Earnings Call Transcript: Q4 2022

Jan 24, 2023, 8:30 AM EST - 3 years ago

Johnson & Johnson Earnings Call Transcript: Q4 2022


Johnson & Johnson Transcript: JPMorgan Healthcare Conference

Jan 9, 2023, 12:45 PM EST - 3 years ago

Johnson & Johnson Transcript: JPMorgan Healthcare Conference


Johnson & Johnson Transcript: M&A Announcement

Nov 1, 2022, 8:00 AM EDT - 3 years ago

Johnson & Johnson Transcript: M&A Announcement


Johnson & Johnson Earnings Call Transcript: Q3 2022

Oct 18, 2022, 8:00 AM EDT - 3 years ago

Johnson & Johnson Earnings Call Transcript: Q3 2022


Johnson & Johnson Earnings Call Transcript: Q2 2022

Jul 18, 2022, 8:46 PM EDT - 4 years ago

Johnson & Johnson Earnings Call Transcript: Q2 2022


Johnson & Johnson Earnings Call Transcript: Q1 2022

Apr 19, 2022, 6:24 AM EDT - 4 years ago

Johnson & Johnson Earnings Call Transcript: Q1 2022


Johnson & Johnson Earnings Call Transcript: Q4 2021

Jan 25, 2022, 12:40 PM EST - 4 years ago

Johnson & Johnson Earnings Call Transcript: Q4 2021


Johnson & Johnson Transcript: Investor Update

Nov 11, 2021, 7:00 PM EST - 4 years ago

Johnson & Johnson Transcript: Investor Update


Johnson & Johnson Earnings Call Transcript: Q3 2021

Oct 18, 2021, 8:00 PM EDT - 4 years ago

Johnson & Johnson Earnings Call Transcript: Q3 2021


Johnson & Johnson Earnings Call Transcript: Q2 2021

Jul 21, 2021, 2:00 AM EDT - 5 years ago

Johnson & Johnson Earnings Call Transcript: Q2 2021


Johnson & Johnson Transcript: ESG Update

Jun 23, 2021, 8:25 AM EDT - 5 years ago

Johnson & Johnson Transcript: ESG Update


Johnson & Johnson Transcript: AGM 2021

Apr 21, 2021, 8:00 PM EDT - 5 years ago

Johnson & Johnson Transcript: AGM 2021


Johnson & Johnson Earnings Call Transcript: Q1 2021

Apr 20, 2021, 8:45 AM EDT - 5 years ago

Johnson & Johnson Earnings Call Transcript: Q1 2021


Johnson & Johnson Earnings Call Transcript: Q4 2020

Jan 26, 2021, 3:32 AM EST - 5 years ago

Johnson & Johnson Earnings Call Transcript: Q4 2020


Johnson & Johnson Earnings Call Transcript: Q3 2020

Oct 13, 2020, 3:34 AM EDT - 6 years ago

Johnson & Johnson Earnings Call Transcript: Q3 2020


Johnson & Johnson Earnings Call Transcript: Q2 2020

Jun 27, 2020, 3:38 AM EDT - 6 years ago

Johnson & Johnson Earnings Call Transcript: Q2 2020


Johnson & Johnson Earnings Call Transcript: Q1 2020

Apr 14, 2020, 3:39 AM EDT - 6 years ago

Johnson & Johnson Earnings Call Transcript: Q1 2020


Johnson & Johnson Earnings Call Transcript: Q4 2019

Jan 22, 2020, 8:30 AM EST - 6 years ago

Johnson & Johnson Earnings Call Transcript: Q4 2019


Johnson & Johnson Earnings Call Transcript: Q3 2019

Oct 15, 2019, 8:30 AM EDT - 7 years ago

Johnson & Johnson Earnings Call Transcript: Q3 2019


Johnson & Johnson Earnings Call Transcript: Q2 2019

Jul 16, 2019, 8:30 AM EDT - 7 years ago

Johnson & Johnson Earnings Call Transcript: Q2 2019


Johnson & Johnson Earnings Call Transcript: Q1 2019

Apr 16, 2019, 8:30 AM EDT - 7 years ago

Johnson & Johnson Earnings Call Transcript: Q1 2019


Johnson & Johnson Earnings Call Transcript: Q4 2018

Jan 22, 2019, 8:30 AM EST - 7 years ago

Johnson & Johnson Earnings Call Transcript: Q4 2018


Johnson & Johnson Earnings Call Transcript: Q3 2018

Oct 16, 2018, 8:30 AM EDT - 8 years ago

Johnson & Johnson Earnings Call Transcript: Q3 2018


Johnson & Johnson Earnings Call Transcript: Q2 2018

Jul 17, 2018, 8:30 AM EDT - 8 years ago

Johnson & Johnson Earnings Call Transcript: Q2 2018


Johnson & Johnson Transcript: Investor Day 2018

May 16, 2018, 8:40 AM EDT - 8 years ago

Johnson & Johnson Transcript: Investor Day 2018


Johnson & Johnson Earnings Call Transcript: Q1 2018

Apr 17, 2018, 8:30 AM EDT - 8 years ago

Johnson & Johnson Earnings Call Transcript: Q1 2018


Johnson & Johnson Earnings Call Transcript: Q4 2017

Jan 23, 2018, 8:30 AM EST - 8 years ago

Johnson & Johnson Earnings Call Transcript: Q4 2017


Johnson & Johnson Earnings Call Transcript: Q3 2017

Oct 17, 2017, 8:30 AM EDT - 9 years ago

Johnson & Johnson Earnings Call Transcript: Q3 2017


Johnson & Johnson Earnings Call Transcript: Q2 2017

Jul 18, 2017, 8:30 AM EDT - 9 years ago

Johnson & Johnson Earnings Call Transcript: Q2 2017


Johnson & Johnson Earnings Call Transcript: Q1 2017

Apr 18, 2017, 8:30 AM EDT - 9 years ago

Johnson & Johnson Earnings Call Transcript: Q1 2017


Johnson & Johnson Earnings Call Transcript: Q4 2016

Jan 24, 2017, 8:30 AM EST - 10 years ago

Johnson & Johnson Earnings Call Transcript: Q4 2016


Johnson & Johnson Earnings Call Transcript: Q3 2016

Oct 18, 2016, 8:30 AM EDT - 10 years ago

Johnson & Johnson Earnings Call Transcript: Q3 2016


Johnson & Johnson Earnings Call Transcript: Q2 2016

Jul 19, 2016, 8:30 AM EDT - 10 years ago

Johnson & Johnson Earnings Call Transcript: Q2 2016


Johnson & Johnson Earnings Call Transcript: Q1 2016

Apr 19, 2016, 8:30 AM EDT - 10 years ago

Johnson & Johnson Earnings Call Transcript: Q1 2016


Johnson & Johnson Earnings Call Transcript: Q4 2015

Jan 26, 2016, 8:30 AM EST - 11 years ago

Johnson & Johnson Earnings Call Transcript: Q4 2015


Johnson & Johnson Earnings Call Transcript: Q3 2015

Oct 13, 2015, 8:30 AM EDT - 11 years ago

Johnson & Johnson Earnings Call Transcript: Q3 2015


Johnson & Johnson Earnings Call Transcript: Q2 2015

Jul 14, 2015, 8:30 AM EDT - 11 years ago

Johnson & Johnson Earnings Call Transcript: Q2 2015


Johnson & Johnson Earnings Call Transcript: Q1 2015

Apr 14, 2015, 8:30 AM EDT - 12 years ago

Johnson & Johnson Earnings Call Transcript: Q1 2015


backtesttrend
backtesttrend Apr. 28 at 8:31 PM
Are the targets factoring in cyclical mean reversion? 📊 Margin expansion in memory is real, but parabolic moves invite gamma unwinds. Trim into strength, hedge tail risk with puts. Capital preservation > chasing prints. $MU $CAT $JNJ 👉If this helps, tap @backtesttrend
0 · Reply
DragonAlgo
DragonAlgo Apr. 28 at 5:01 PM
🐉 $JNJ CALL — DragonAlgo® Signal Contract: JNJ CALL Expiry: 2026-05-01 | Strike: $227.50 | Type: CALL Option Plan (premium): Entry: $3.13 Stop: $2.26 TP1: $4.08 TP2: $5.33 TP3: $7.52 Risk preset by model constraints. 🔗 https://dragonalgo.com
0 · Reply
MeanReverter_
MeanReverter_ Apr. 28 at 4:25 PM
Headline just hit and this is the kind of macro catalyst traders can’t ignore Trump is bringing major players to the White House — spanning semis, autos, steel, pharma, and AI infra. That’s not random… that’s capital allocation + policy direction in real time. Here’s how I’m reading the flow: • $NVDA → still the king of AI infra. Any renewed push = tailwind • $TSM → direct beneficiary of U.S. chip reshoring narrative • $TM → foreign auto giant, could gain from localized production incentives • $JNJ → tied to domestic pharma expansion, policy support matters • $CLF → classic sleeper, steel demand rises if U.S. manufacturing ramps This isn’t just headlines — this is positioning for where money could rotate next. Watch volume + relative strength closely. If this gains traction, these names won’t stay quiet for long. Stay sharp — narratives like this can reprice sectors fast. Curious about the full approach?👉 Check the @MeanReverter_
0 · Reply
NRG8
NRG8 Apr. 28 at 3:09 PM
0 · Reply
DeadInvestor
DeadInvestor Apr. 28 at 2:41 PM
$TVTX This should be around $65 / share, or roughly mrkt cap 2x peak sales of $3.1 billion. Awaiting news to leak on potential acquirers, such as $LLY or $NVS or $JNJ or $AZN . $75 to $80 take out price well within the realm of possibility. But, if share price doesn’t climb from this $40 floor, buyout price might be undervalued.
0 · Reply
NewEarth
NewEarth Apr. 28 at 12:01 PM
0 · Reply
Goldenpoint9
Goldenpoint9 Apr. 28 at 9:24 AM
0 · Reply
grampslol
grampslol Apr. 28 at 9:01 AM
Poor $MNKD pumper clan...smh... deluding himself as he tries to deceive others about this pennyland inhaled insulin flop drug company...he knows it's Afizzle $IBB $SPY $JNJ
0 · Reply
clan
clan Apr. 28 at 8:28 AM
$MNKD Follow the pros.🤑 Ignore the triggered trolls👹. Inhale your insulin.🚫💉 MNKD up and to the right from here.↗️ Multiple approvals incoming. Load the boat. BULLISH🐂 Mannkind Corp. = premier bio. co. $SPY $IBB $JNJ
0 · Reply
focafoca99
focafoca99 Apr. 28 at 5:42 AM
$JNJ entered the calendar for Bernstein's Strategic Decisions Conference with a planned company appearance. https://www.rapidticker.com/news/jnj-johnson-amp-johnson-to-participate-b6d983
0 · Reply
Suite510
Suite510 Apr. 28 at 1:20 AM
$JNJ $SPX $SPY $ABT oh this almost looks like a JNJ type verdict, guessing a real bankruptcy still a possibility 🤷🤣 A jury in Georgia has ordered Monsanto parent Bayer to pay nearly $2.1 billion in damages to a man who says the company’s Roundup weed killer caused his cancer.
1 · Reply
LiveCommander
LiveCommander Apr. 27 at 10:30 PM
Question: where's the math? Bullish narratives stacking on $IGV momentum and AI productivity ignore base-rate exhaustion signals 📊 Risk assessment: melt-up tape, but vol skew is cheap. Positioning advice: trim delta into strength, hedge via puts on $XLK, rotate to defensives like $PG, $JNJ for ballast.
0 · Reply
LiveCommander
LiveCommander Apr. 27 at 10:13 PM
Question: where's the actual price discovery edge here? Superforecaster consensus ≠ deep two-way liquidity. Until institutional flow validates these benchmarks, treat as signal, not hedge instrument. 🛡️ Stay sized small, demand wider spreads. $CME $ICE $JNJ
0 · Reply
DragonAlgo
DragonAlgo Apr. 27 at 9:57 PM
🐉 $JNJ PUT — DragonAlgo® Signal Contract: JNJ PUT Expiry: 2026-05-01 | Strike: $225.00 | Type: PUT Option Plan (premium): Entry: $2.29 Stop: $1.65 TP1: $2.97 TP2: $3.88 TP3: $5.48 🔗 https://dragonalgo.com
0 · Reply
ElliottwaveForecast
ElliottwaveForecast Apr. 27 at 9:35 PM
Can you identify when a pullback is actually creating a high‑probability buy zone? $JNJ is heading into the 227.8–215.8 area, where buyers are expected to show up. Learn this skill and apply it to any market. Check out this 👉 https://elliottwave-forecast.com/stock-market/jnj-forecast-buyers-should-enter-227-8-215-8-area #elliottwave #stocks
0 · Reply
focafoca99
focafoca99 Apr. 27 at 9:13 PM
$JNJ received FDA Priority Review for IMAAVY in warm autoimmune hemolytic anemia. https://www.rapidticker.com/news/jnj-fda-grants-priority-review-for-09369e
0 · Reply
LiveCommander
LiveCommander Apr. 27 at 9:01 PM
Risk assessment: $C parabolic extension without volume confirmation flags exhaustion. Reward/risk skewed unfavorably at these levels 📊 Positioning advice: Trim into strength, trail stops below prior pivot. Rotate proceeds toward defensives like $JNJ or $PG. Chasing momentum here offers poor expectancy.
0 · Reply
Buy_SoFi
Buy_SoFi Apr. 27 at 7:34 PM
$TLTFF <---- 👀 More and more eyes on this gem. Don't get me wrong, there is still some de-risking to do but by that time I expect the price to be double or triple what it is today. Volume increasing daily which is nice to see $MRK $JNJ $IBRX $CGON
0 · Reply
maq34
maq34 Apr. 27 at 5:19 PM
$ATRC $JNJ $MDT $HIMS $PFE https://www.marketbeat.com/instant-alerts/filing-oak-harvest-investment-services-makes-new-148-million-investment-in-atricure-inc-atrc-2026-04-18/ https://www.marketbeat.com/instant-alerts/filing-oak-harvest-investment-services-makes-new-148-million-investment-in-atricure-inc-atrc-2026-04-18/
0 · Reply
AltcoinsPumpAndDump2024
AltcoinsPumpAndDump2024 Apr. 27 at 4:45 PM
$JNJ what’s up with this pos?
0 · Reply
NRG8
NRG8 Apr. 27 at 4:17 PM
0 · Reply
Buy_SoFi
Buy_SoFi Apr. 27 at 3:01 PM
$TLTFF 👀Theralase Technologies: Ruvidar and Rutherin showing amazing results. NMIBS, MIBC, Lung, Brain, Pancreatic, Colorectal AND HSV treatment in the pipeline. One of the most promising biotech stock in the world today. $IBRX $MRK $JNJ $GILD
0 · Reply